Reata Pharmaceuticals：Investor Relations
Investor Relations
2023年6月27日—Reataisabiopharmaceuticalcompanythatdevelopsnoveltherapeuticsforpatientswithseriousorlife-threateningdiseasesbytargeting ...。其他文章還包含有：「ReataPharmaceuticalsInc.」、「Investors」、「ReataPharmaceuticalsInc.」、「ReataPharmaceuticals」、「ReataPharmaceuticals」、「Product」、「BiogenCompletesAcquisitionofReataPharmaceuticals」、「ContactUs」
查看更多 離開網站
Reata Pharmaceuticals Inc.
https://reatapharma.com
At Reata Pharmaceuticals, our mission is to develop innovative therapies that change patients' lives for the better.
Investors
https://www.reatapharma.com
Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc. July 28, 2023. Reata Pharmaceuticals Announces Biogen to Acquire Reata ...
Reata Pharmaceuticals Inc.
https://www.reatapharma.com
Reata has active clinical, preclinical, and internal discovery programs in many significant disease areas. We focus on molecular pathways that regulate ...
Reata Pharmaceuticals
https://en.wikipedia.org
Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, it is primarily focused on investigating experimental oral ...
Reata Pharmaceuticals
https://www.moneydj.com
Reata Pharmaceuticals, Inc.(RETA.US)成立於2002年，總部位於美國德州厄汶，前身為Reata Discovery, Inc.，2005年5月更為現名，為一家臨床階段的生物製藥公司，專注於 ...
Product
https://www.reatapharma.com
Reata Pharmaceuticals has been acquired by Biogen. Please visit www.biogen.com for more information. Site Search. search.
Biogen Completes Acquisition of Reata Pharmaceuticals
https://investors.biogen.com
(Nasdaq: BIIB) – has completed the acquisition of Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a company focused on developing therapeutics ...
Contact Us
https://www.reatapharma.com
Reata Locations ; Main Phone Line (972) 865-2219 (855) 55-REATA (toll-free) ; Business Development [email protected] ; Main Phone Line (972) 865-2219 (855) 55- ...